NDC 69448-015-05

HERCESSI 150 mg/7.4mL

Trastuzumab-strf · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

No Recall History

HERCESSI is a injection, powder, lyophilized, for solution containing trastuzumab-strf at a strength of 150 mg/7.4mL. Manufactured by Accord BioPharma Inc..

Key Facts

Brand Name: HERCESSI
Generic Name: Trastuzumab-strf
NDC Code (Package): 69448-015-05
NDC Code (Product): 69448-015
Manufacturer: Accord BioPharma Inc.
Strength: 150 mg/7.4mL
Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Marketing Status
Application #: BLA761346
Marketing Start: 01/01/2025

Recall History

No Recall History

View Full Drug Page

HERCESSI — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.